Brief: AB&B Says China CDE, U.S. FDA Approve IND Application Of Co's RSV Vaccine

Ab&B Bio Tech JS

17/08/2025 12:25

Aug 17 (Reuters) - Ab&B Bio Tech Co Ltd JS 2627.HK:

SAYS CHINA CDE, U.S. FDA APPROVE INVESTIGATIONAL NEW DRUG (IND)  APPLICATION OF CO'S RECOMBINANT RSV VACCINE

Source text

Further company coverage: 2627.HK

 (Reporting by Hong Kong newsroom)

 ((donny.kwok@thomsonreuters.com; +852 3462 7745;))